葛兰素史克Glaxosmithkline plc (GSK) 2002年年度报告「LSE」.pdf

1、The Impact of MedicinesAnnual Report 2002Do more,feel better,live GlaxoSmithKline plc is an English public limited company.Its shares are listed on the London Stock Exchange and the New York Stock Exchange.GlaxoSmithKline plc acquired Glaxo Wellcome plc and SmithKline Beecham plc on 27th December 20

2、00 by way of a scheme of arrangement for the merger of the two companies which became effective on 27th December 2000.This report is the Annual Report of GlaxoSmithKline plc for the year ended 31st December 2002.It comprises in a single document the Annual Report of the company in accordance with Un

3、ited Kingdom requirements and the Annual Report on Form 20-F to the Securities and Exchange Commission in the United States of America.A summary report on the year,the Annual Review 2002,intendedfor the investor not needing the full detail of the Annual Report,is produced as a separate document.The

4、Annual Review includesthe joint statement by the Chairman and the Chief ExecutiveOfficer,a summary review of operations,summary financial statements and a summary remuneration report.The Annual Review is issued to all shareholders.The AnnualReport is issued to shareholders who have elected to receiv

5、e it.Both documents are available on GlaxoSmithKlines corporate website at .WebsiteGlaxoSmithKlines website, gives additional information on the Group.Information made available on the website does not constitute part of this Annual Report.MissionOur global quest is to improve the quality of human l

6、ife by enabling people to do more,feel better and live longer.Our SpiritWe undertake our quest with the enthusiasm of entrepreneurs,excited by the constant search for innovation.We valueperformance achieved with integrity.We will attain success as a world class global leader with each and everyone o